http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
This week's FierceLifeSci is brought to you by ExL Events.
|
| No other conference provides this much detail on partnership and pipeline strategies for biotech leaders. Based on feedback from our attendees and readers, this year’s all-new agenda offers unprecedented depth into how to secure long-term funding for biotech companies while avoiding the mishaps common to early-stage research. |
|
|
PROGRAM HIGHLIGHTS Over 10 hours of networking during a three-day event Two in-depth tracks: Strategic Deal-Making and Partnering Breakthroughs in Guiding Early-Stage Research Two interactive workshops: Improve Strategic Partnerships in Drug Repurposing Add Orphan Indications to Accelerate Development |
|
|
PLUS — Over 90 speakers, including: |
|
|
| Roy Baynes, CMO, Senior Vice President, Head of Clinical Development, MERCK |
| | Douglas Ingram, CEO, SAREPTA THERAPEUTICS |
| | Lawrence Bloch, President, INFINITY PHARMACEUTICALS |
| | Aradhana Sarin, Senior Vice President, Head of Business Development and Strategy, ALEXION PHARMACEUTICALS |
|
|
| Julie Krop, CMO, AMAG PHARMACEUTICALS |
| | | Stephane Bancel, CEO, MODERNA THERAPEUTICS |
| | Barbara Dalton, Vice President, Venture Capital, PFIZER |
|
|
| Sridhar Ramaswamy, Vice President, R&D, TESARO |
| | Nouhad Husseini, Vice President, Head of Business Development, REGENERON |
| | Salim Mujais, Senior Vice President, Global Therapeutics Head, Specialty Pharma, ASTELLAS |
| | Jeremy Sohn, Vice President, Global Head of Digital Business Development and Licensing, NOVARTIS |
|
|
| Karen Anderson, Senior Vice President, Chief Human Resources Officer, ALNYLAM PHARMACEUTICALS |
| | Alex Waldron, Chief Commercial Officer, PEAR THERAPEUTICS |
|
|
| Register today to save your seat for this one-of-a-kind learning and networking experience! Advance conference rates expire Friday, August 17th. I look forward to seeing you in Boston this fall! Sincerely, |
|
| Matt Greenbaum
Production Team Leader
ExL Events, a division of Questex, LLC |
| | Rebecca Willumson
Publisher
FierceBiotech |
|
|
|
| For information on sponsorship and exhibition opportunities, please contact Andrew Sinetar at 212-400-6237 or [email protected]. |
|
|
Copyright © 2018 ExL Events, All rights reserved.
494 8th Avenue, 4th Floor, New York, NY 10001
Phone: 212-400-6240
Email: [email protected]
|
|
|
| Want to reach 150,000+ FierceBiotech subscribers with your own message?
Contact [email protected] or call 202-824-5074.
About this email: In order to receive FierceBiotech for free, we ask that you accept an occasional email promotion from our sponsors. We carefully screen each promotion and never sell or give away your personal information. If you do not want to receive these messages, you can unsubscribe entirely from FierceBiotech.
Click here to unsubscribe.
FierceMarkets, a division of Questex, LLC
1900 L St. NW Suite 400
Washington, DC 20036 |
.
